Related references
Note: Only part of the references are listed.Cardiovascular complications of cirrhosis
S. Moller et al.
GUT (2008)
Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort study
Peter Jepsen et al.
HEPATOLOGY (2008)
Pathogenetic background for treatment of ascites and hepatorenal syndrome
Soren Moller et al.
HEPATOLOGY INTERNATIONAL (2008)
295 LOW CARDIAC INDEX PREDICTS SURVIVAL AND RENAL FAILURE IN PATIENTS WITH ASCITES. EVIDENCE OF A HEART-KIDNEY AXIS IN CIRRHOSIS
A. Krag et al.
JOURNAL OF HEPATOLOGY (2008)
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis
Paolo Caraceni et al.
JOURNAL OF HEPATOLOGY (2008)
Effect of chronic β-blockade on QT interval in patients with liver cirrhosis
Andrea Zarabruni et al.
JOURNAL OF HEPATOLOGY (2008)
Hemodynamic alterations in liver cirrhosis
Giorgio La Villa et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Predicting mortality in cirrhosis -: Serum sodium helps
Andres Cardenas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diurnal variation and dispersion in QT interval in cirrhosis: Relation to haemodynamic changes
Stig Hansen et al.
JOURNAL OF HEPATOLOGY (2007)
Acute and chronic ventricular-arterial coupling in systole and diastole - Insights from an elderly hypertensive model
Brian P. Shapiro et al.
HYPERTENSION (2007)
Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function
Sean Balmain et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt
Massimo Cazzaniga et al.
GUT (2007)
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome
Vicente Arroyo et al.
JOURNAL OF HEPATOLOGY (2007)
Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension
R. Wiest et al.
PEPTIDES (2007)
Cardiac effects of terlipressin in cirrhosis. Unmasking a cirrhotic cardiomyopathy?
A. Krag et al.
JOURNAL OF HEPATOLOGY (2007)
Water and sodium retention in edematous disorders: Role of vasopressin and aldosterone
Robert W. Schrier
AMERICAN JOURNAL OF MEDICINE (2006)
Cardiac electrophysiological abnormalities in patients with cirrhosis
A Zambruni et al.
JOURNAL OF HEPATOLOGY (2006)
Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state
JG Abraldes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites
JW Ferguson et al.
GUT (2006)
Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume
S Moller et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats
M Hennenberg et al.
GASTROENTEROLOGY (2006)
The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
Y Iwakiri et al.
HEPATOLOGY (2006)
Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis
DA Langer et al.
JOURNAL OF HEPATOLOGY (2006)
Brain metabolism of N-13-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography
S Keiding et al.
HEPATOLOGY (2006)
Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis
MR Ebrahimkhani et al.
GUT (2005)
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites
M Bolognesi et al.
GUT (2005)
Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats
M Fernandez et al.
JOURNAL OF HEPATOLOGY (2005)
Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis
JH Henriksen et al.
JOURNAL OF HEPATOLOGY (2004)
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease
JH Henriksen et al.
GUT (2003)
Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender
S Moller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide
A Helmy et al.
GUT (2003)
Dyssynchronous electrical and mechanical systole in patients with cirrhosis
JH Henriksen et al.
JOURNAL OF HEPATOLOGY (2002)
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
R Wiest et al.
HEPATOLOGY (2002)
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
S Moller et al.
HEART (2002)
Total effective vascular compliance in patients with cirrhosis. Effects of propranolol
V Andreu et al.
JOURNAL OF HEPATOLOGY (2002)
Cardiovascular dysfunction in cirrhosis - Pathophysiological evidence of a cirrhotic cardiomyopathy
S Moller et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems
JH Henriksen et al.
GUT (2001)
Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis
JH Henriksen et al.
JOURNAL OF HEPATOLOGY (2001)
Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis
JH Henriksen et al.
JOURNAL OF HEPATOLOGY (2001)
Cirrhotic cardiomyopathy and liver transplantation
RP Myers et al.
LIVER TRANSPLANTATION (2000)
Share Paper
